We find that FCCP-induced mitochondrial damage drives a robust loss of Miro at its expected molecular weight dependent on PINK1 and Parkin, and this is disrupted in PD patient-derived fibroblasts (lacking functional Parkin). This evidence concerns the gene PRKN and Parkinson disease.